The Latest
-
Abbott reports diagnostics growth since $21B Exact Sciences buy
The Exact Sciences acquisition, which closed in March, fueled more than 40% growth in Abbott’s diagnostics sales in the second quarter.
-
Vicarious Surgical board proposes dissolving the company
The robot developer’s board set a July 21 date for shareholders to vote on a proposal to wind down operations amid expectations for continued operating losses.
-
Zimmer Biomet names new Asia Pacific president
Chintan Desai, formerly of Alcon and GE HealthCare, has experience leading medtech teams in the region.
-
J&J misses company expectations for cardiovascular in Q2
Sales in Johnson & Johnson’s Abiomed business declined in the second quarter due to procedure volume pressures related to its Impella device.
-
SS Innovations names Sarah Romano as CFO
Romano, who is joining from rival robotic surgery company Vicarious Surgical, will step into a position that has been held by a series of executives over the past year.
-
Edwards will pay $10M to settle FTC charges of skirting antitrust review
The artificial heart valve maker will settle allegations it deliberately structured its deal to acquire JC Medical to sidestep a Hart-Scott-Rodino review.
-
Medtronic recalls heart valve delivery catheter for risk of tip detaching
Certain delivery systems that are used to insert a pulmonary valve have an increased risk of distal tip detachment, the company said. The valve itself is not affected by the recall.
-
HistoSonics wins Europe’s CE mark for histotripsy system
HistoSonics’ phased commercial rollout of the Edison system will initially target centers specializing in liver tumor treatment.
-
Freenome colorectal cancer test data improve on earlier results
The new study results could make Abbott, which has an agreement with Freenome to market the blood-based test, the dominant player in colorectal cancer screening, Evercore ISI analysts said.
-
Whoop tests wearable platform in joint replacement recovery
The program, a partnership with Kinomatic, will use biometric data and care coordination between visits to support recovery after surgery.
-
Top medtech executive moves in 2026
Medtronic created a new position, while Illumina built out its C-suite and DePuy Synthes named its CFO ahead of a split with J&J. Read MedTech Dive’s roundup for all the details.
Updated July 13, 2026 -
Illumina builds out C-suite with 2 new execs
The gene sequencing company this week named a new chief commercial officer and chief legal officer.
-
Medicaroid wins Europe’s CE mark for Hinotori surgical robot
The Japanese medical robotics company, a joint venture between Kawasaki and Sysmex, is preparing for a European launch after expanding in the Asia-Pacific region.
-
Stereotaxis closes Robocath takeover
With the acquisition of Robocath completed, Stereotaxis intends to accelerate development of next-generation robotic technologies for endovascular procedures.
-
4 takeaways from MDUFA VI draft agreement
The draft agreement outlines the Food and Drug Administration’s goals for medical device reviews from 2028 to 2032.
-
J&J wins FDA approval for dual-energy ablation catheter
Johnson & Johnson expects U.S. physicians to perform the first procedures with the device this summer as it starts a phased commercial rollout.
-
Resmed to sell MatrixCare for $490M to private equity firm
Selling the software business to Frazier Healthcare Partners will allow the respiratory device maker to shift more resources to faster-growing parts of its portfolio.
-
Physicians’ wearable data use hampered by reimbursement, workflow barriers: survey
“We have all this data that’s available, but it’s actually not actionable because we don’t have a way to get it into clinical workflow,” said American Medical Association CEO Dr. John Whyte.
-
Top surgical robotics stories in the first half of 2026
The market for robotic surgery got more competitive this year, with Medtronic, Stryker, CMR Surgical and Distalmotion introducing new platforms. Check up on their progress and more in MedTech Dive’s roundup of robotics coverage.
-
Penumbra starts trial of clot removal device in stroke subgroup
Penumbra, which is set to become part of Boston Scientific this year, is running the trial to inform the treatment of a type of medium-vessel blockage.
-
AdaptHealth discloses patient data was stolen in cyberattack
The medical device supplier said that a threat actor accessed company systems through a social engineering attack.
-
Top 10 medtech deals in the first half of 2026
Boston Scientific, Medtronic and Stryker were among the companies to ink deals to move into markets that are expanding quickly.
-
Insulet launches Omnipod 5 in Spain
A high rate of continuous glucose monitor adoption and low level of automated insulin delivery system penetration make Spain an attractive market for Insulet.
-
Top diabetes tech stories from the first half of 2026
Diabetes technology news has been off to a fast start this year. Here are some highlights of MedTech Dive’s coverage from 2026.
-
Medtronic starts to notify people affected by cyberattack
The medtech giant said it currently has no evidence that the accessed data has been posted to the internet.